Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Gresham College Lectures
Gresham College
The Sod Pod
Grassland Agro
ECO Tuin Talks
ECOstyle
Ground Truths
Eric Topol
Os três elementos
Os três elementos / TocaCast
CountrySlide
Negus, McInerney-Riley, Prideaux
The Biblical Hitmen
Stephen DeMatties Jr
Quirks and Quarks
CBC
Podcast de Juan Ramón Rallo
Juan Ramón Rallo
Spritz e Scienza
crazyjimmy
Verbal Echo
Monica Martin and Co-Host Sara Rowe
E o Resto é... Ciência
Observador
Grey Dynamics
Grey Dynamics
Physio Edge podcast with David Pope
David Pope
wifiCFI
wifiCFI
二奇物语
剁椒，老猫
Seventy3
任雨山
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Глобальный доступ на рынок медицинских изделий
Pure Global
चिकित्सा उपकरण वैश्विक बाजार पहुंच
Pure Global
Tıbbi Cihazlar Küresel Pazar Erişimi
Pure Global
Akses Pasar Global Alat Kesehatan
Pure Global
Travelers In The Night
Albert D. Grauer
Icebergs y Misterios
Icebergs y Misterios
Astronomie : Fragments d'Univers
Astronomie : Fragments d'Univers
Yoga Therapy Hour with Amy Wheeler
Amy Wheeler
Science Tech Brief By HackerNoon
HackerNoon
Futurism Tech Brief By HackerNoon
HackerNoon
Paranormal UK Radio Network
Paranormal UK Radio Network
Typical Skeptic Podcast
Robert Kalil
Interplace
Brad Weed
Georgia Today
Georgia Public Broadcasting
Western Slope Skies
Farming Today
BBC Radio 4
艾灸养生108招 |病来了，不用怕
冯名雨艾灸
UnHerd with Freddie Sayers
UnHerd
Science
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
The cell and gene therapy industry faces massive hurdles—cost, scalability, and the need for highly skilled operators have historically limited the reach of these transformative treatments. advanced therapy medicinal pro...
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.